Uritos

Uritos

Manufacturer:

Eisai

Distributor:

DKSH
Concise Prescribing Info
Contents
Imidafenacin
Indications/Uses
Urinary urgency, urinary frequency & urge urinary incontinence associated w/ overactive bladder.
Dosage/Direction for Use
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Patients w/ urinary retention, occluded pyloric region/duodenum/intestine or paralytic ileus, decreased GI movements & muscular tension, narrow-angle glaucoma, myasthenia gravis, severe heart disease.
Special Precautions
Patients w/ dysuria, arrhythmia, hepatic & renal dysfunction, dementia or cognitive dysfunction, Parkinsonian symptoms or cerebrovascular disorder, ulcerative colitis, hyperthyroidism. Monitor the residual urine vol in patients w/ lower urinary tract obstructive disease including BPH prior to treatment. May induce eye accommodation disorder including photophobia, blurred vision & eye abnormality in patients who operate potentially hazardous machinery eg, driving a car. Not for patients w/ dementia or cognitive dysfunction. Pregnancy & lactation. Childn, low birthwt babies, neonates, nursing infants. Elderly.
Adverse Reactions
Thirst, constipation, photophobia, blurred vision, sleepiness, stomach discomfort, increased triglyceride, increased γ-GTP.
Drug Interactions
Increased Cmax & AUC w/ CYP3A4 inhibitors (eg, itraconazole, erythromycin, clarithromycin). Enhanced anticholinergic effect w/ TCAs, anticholinergic & antihistaminic agents, phenothiazines, MAIOs.
MIMS Class
Drugs for Bladder & Prostate Disorders
ATC Classification
G04BD14 - imidafenacin ; Belongs to the class of urinary antispasmodics.
Presentation/Packing
Form
Uritos tab 0.1 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in